---
title: "中国医学科学院林东昕院士等团队50+突破！经典通路首次解锁食管鳞癌命门！"
date: 2025-09-15T00:19:02Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
中国医学科学院林东昕院士等团队50+突破！经典通路首次解锁食管鳞癌命门！ by 生信人
------
<div><section nodeleaf=""><img data-imgfileid="503761344" data-ratio="0.31266666666666665" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVJgPpzr0Nj6nqwJJYoZsFfSib0ianRFlShg2q7j8L3Rj6JfYhaviamviaIibickuLibZZ1Cv6APwjJ6nn2Q/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1500" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVJgPpzr0Nj6nqwJJYoZsFfSib0ianRFlShg2q7j8L3Rj6JfYhaviamviaIibickuLibZZ1Cv6APwjJ6nn2Q/640?wx_fmt=png&amp;from=appmsg"></section><p data-pm-slice="0 0 []"><font face="微软雅黑"><span leaf=""><span textstyle="">食管鳞状细胞癌（</span></span></font><span leaf=""><span textstyle="">ESCC）作为中国高发的消化道恶性肿瘤，因</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">诊断晚、预后差且治疗手段有限</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">，其分子机制研究迫在眉睫。近期</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">中国医学科学院肿瘤医院</span></span></font><span leaf=""><span textstyle="">/国家癌症中心的吴晨、林东昕、张少森研究团队</span><span textstyle="">发表于</span><span textstyle="">Signal Transduction and Targeted Therapy</span><span textstyle="">的研究《</span><span textstyle="">Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma</span><span textstyle="">》</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">1）首次阐明了</span></span></font><span leaf=""><span textstyle=""> Notch 信号通过NOTCH1-USP5-STAT3轴调控ESCC血管生成的新机制，为靶向治疗提供了全新思路。</span></span><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiau4QP1hNrAWVtVjX42zhJqzMlhMEPwrjCfxicTEgIqgibNPgBc2R9WGGA/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="0.3140625" data-s="300,640" data-type="jpeg" data-w="1280" type="block" data-imgfileid="503761776" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiau4QP1hNrAWVtVjX42zhJqzMlhMEPwrjCfxicTEgIqgibNPgBc2R9WGGA/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">1</span></span></font></p><section data-pm-slice="13 4 []"><section><section><section><section><section><section><section><section><span><strong><span><span leaf="">向中国医师致敬！</span></span></strong></span></section></section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/640?wx_fmt=png&amp;from=appmsg" data-ratio="1" data-s="300,640" data-type="png" data-w="150" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/0?wx_fmt=png&amp;from=appmsg" data-cropselx2="185" data-cropsely2="185" data-imgfileid="503761775" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/640?wx_fmt=png&amp;from=appmsg"></section></section><section><section><section><section><p><span><strong><span leaf="">多组学，多维度探究癌症免疫机制</span></strong></span></p></section></section></section></section></section></section></section></section></section></section><span><p></p></span></section><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">研究背景：</span></span></font></b><b><span leaf=""><span textstyle="">ESCC治疗困境与Notch信号的"双面性"</span></span></b><b><span><p></p></span></b></p><p><span leaf=""><span textstyle="">ESCC在东亚地区发病率居高不下，且多数患者确诊时已处于晚期，导致</span></span><b><span leaf=""><span textstyle="">5年生存率不足20%</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。现有化疗、放疗等治疗手段对晚期患者疗效有限，</span></span></font><b><font face="微软雅黑"><span leaf=""><span textstyle="">肿瘤的高侵袭性和耐药性</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">是主要障碍。因此，解析</span></span></font><span leaf=""><span textstyle="">ESCC进展的关键分子机制，寻找新的治疗靶点成为当务之急。</span></span><span><p></p></span></p><p><span leaf=""><span textstyle="">Notch信号通路作为进化上高度保守的细胞间通讯通路，在胚胎发育、细胞命运决定中发挥核心作用，而其</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">在癌症中的功能却呈现</span></span></font><span leaf=""><span textstyle="">"双面性"：在部分肿瘤中表现为抑癌作用，在另一些肿瘤中则促进恶性进展</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。在</span></span></font><span leaf=""><span textstyle="">ESCC中，NOTCH1是仅次于TP53的高频突变基因（突变率近20%），但有趣的是，正常食管上皮中NOTCH1突变率更高——这提示</span></span><b><span leaf=""><span textstyle="">Notch信号在ESCC发生发展中可能存在阶段特异性作用</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">既往研究显示，</span></span></font><span leaf=""><span textstyle="">Notch信号激活与肿瘤干细胞特性、上皮</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">-</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">间质转化（</span></span></font><span leaf=""><span textstyle="">EMT）等相关，但在ESCC血管生成中的作用尚未明确。血管生成作为肿瘤获取营养和转移的"生命线"，是ESCC进展的关键标志，其分子调控网络的解析对开发抗血管生成疗法至关重要。该研究正是基于这一背景，</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">聚焦</span></span></font><span leaf=""><span textstyle="">Notch信号与ESCC血管生成的关联</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">，试图揭开其中的调控奥秘。</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">研究设计：从单细胞到临床样本的</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">“三级跳”</span></span></font></b><b><span><p></p></span></b></p><table><tbody><tr><td data-colwidth="116" width="63" valign="center"><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">层级</span></span></font></b><b><span><p></p></span></b></p></td><td data-colwidth="151" width="151" valign="center"><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">样本</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">/模型</span></span></font></b><b><span><p></p></span></b></p></td><td data-colwidth="127" width="127" valign="center"><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">关键数据</span></span></font></b><b><span><p></p></span></b></p></td><td data-colwidth="159" width="88" valign="center"><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">目的</span></span></font></b><b><span><p></p></span></b></p></td></tr><tr><td data-colwidth="116" width="63" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">单细胞</span></span></font><span><p></p></span></p></td><td data-colwidth="151" width="151" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">60例ESCC（GSE160269）</span></span></font><span><p></p></span></p></td><td data-colwidth="127" width="127" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">86,933个细胞</span></span></font><span><p></p></span></p></td><td data-colwidth="159" width="88" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">计算</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">Notch与血管生成通路评分</span></span></font><span><p></p></span></p></td></tr><tr><td data-colwidth="116" width="63" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">组织芯片</span></span></font><span><p></p></span></p></td><td data-colwidth="151" width="151" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">312例手术ESCC</span></span></font><span><p></p></span></p></td><td data-colwidth="127" width="127" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">NICD1/CD31/USP5</span></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">多重免疫荧光</span></span></font><span><p></p></span></p></td><td data-colwidth="159" width="88" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">临床相关性</span></span></font><span><p></p></span></p></td></tr><tr><td data-colwidth="116" width="63" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">功能模型</span></span></font><span><p></p></span></p></td><td data-colwidth="151" width="151" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">KYSE30/510/450/150细胞系；Notch1全身/条件敲除小鼠；4-NQO诱导原发瘤</span></span></font><span><p></p></span></p></td><td data-colwidth="127" width="127" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">体外管腔形成、</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">Matrigel plug、NSG 移植瘤</span></span></font><span><p></p></span></p></td><td data-colwidth="159" width="88" valign="center"><p><font face="微软雅黑"><span leaf=""><span textstyle="">机制与药效</span></span></font><span><p></p></span></p></td></tr></tbody></table><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">核心发现：</span></span></font></b><b><span leaf=""><span textstyle="">Notch信号激活与ESCC血管生成及预后密切相关</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">研究团队通过多维度实验，首先</span></span></font><b><font face="微软雅黑"><span leaf=""><span textstyle="">明确了</span></span></font></b><b><span leaf=""><span textstyle="">Notch信号激活与ESCC血管生成的正向关联</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">，且这一关联直接影响患者预后。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">临床样本验证：</span></span></font><span leaf=""><span textstyle="">Notch激活与高血管密度、晚期分期和短生存期相关</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">研究者对</span></span></font><span leaf=""><span textstyle="">60例ESCC患者的单细胞RNA测序数据（GSE160269）分析发现，</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">上皮细胞中</span></span></font><span leaf=""><span textstyle="">Notch信号评分高的肿瘤，其血管生成通路显著富集</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">2</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。进一步在</span></span></font><span leaf=""><span textstyle="">312例 ESCC组织芯片中，通过NICD（Notch信号激活标志物）和CD31（血管内皮标志物）的多重免疫荧光染色，证实</span></span><b><span leaf=""><span textstyle="">NICD1强度与微血管密度呈显著正相关</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">2</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiad2ib5ibfVDyI5VrCchltaGyFibG95OI7xvTr0MOGSuKyb8Lush340iadicg/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="1.0984375" data-s="300,640" data-type="jpeg" data-w="1280" type="block" data-imgfileid="503761777" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiad2ib5ibfVDyI5VrCchltaGyFibG95OI7xvTr0MOGSuKyb8Lush340iadicg/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">2</span></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">更重要的是，临床分层分析显示：晚期</span></span></font><span leaf=""><span textstyle="">ESCC（TNM III/IV期）的NICD1水平显著高于早期（I/II期）（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">2</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）；有淋巴结转移的肿瘤中</span></span></font><span leaf=""><span textstyle="">NICD1激活更强；高NICD1表达患者的中位生存期（26个月）显著短于低表达患者（68个月），且校正其他因素后，高NICD</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">1</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">仍是独立不良预后因素（</span></span></font><span leaf=""><span textstyle="">HR=1.6）（图1h）。这些结果首次在临床层面证实，</span></span><b><span leaf=""><span textstyle="">Notch信号激活可能通过促进血管生成加速ESCC进展</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">体内外功能实验：</span></span></font></b><b><span leaf=""><span textstyle="">Notch信号是ESCC血管生成的"驱动力"</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">为验证</span></span></font><span leaf=""><span textstyle="">Notch信号的直接作用，研究团队开展了系列功能实验：</span></span><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">体外实验：</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">在高表达</span></span></font><span leaf=""><span textstyle="">NICD1的ESCC细胞系（KYSE30、KYSE510）中敲除NOTCH1，其条件培养基可显著抑制人脐静脉内皮细胞（HUVEC）的迁移和管形成能力；而在无NICD1表达的细胞系（KYSE450、KYSE150）中过表达NICD1，条件培养基则显著增强HUVEC的血管生成活性（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">3</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNia2U5mP8WGRRJnOnHxOZkMRvgkvkoEMowAA22ibHJ0GkNtbXA9zyFFadw/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="1.2578456318914335" data-s="300,640" data-type="jpeg" data-w="1179" type="block" data-imgfileid="503761778" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNia2U5mP8WGRRJnOnHxOZkMRvgkvkoEMowAA22ibHJ0GkNtbXA9zyFFadw/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">3</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">体内实验：</span></span></font></b><span leaf=""><span textstyle="">Matrigel栓实验显示，NOTCH1敲除细胞的条件培养基可降低栓内血红蛋白含量和微血管密度；皮下移植瘤模型中，NOTCH1敲除的ESCC细胞形成的肿瘤生长更慢，且微血管密度显著降低（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">3</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）；在</span></span></font><span leaf=""><span textstyle="">4-NQO诱导的小鼠原发ESCC模型中，Notch1敲除小鼠的肿瘤微血管密度显著低于野生型（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">3</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">值得注意的是，</span></span></font><span leaf=""><span textstyle="">CCK-8和Ki-67染色证实，</span></span><b><span leaf=""><span textstyle="">Notch1敲除对肿瘤细胞增殖无显著影响，说明其抑瘤作用主要源于血管生成抑制</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。此外，研究还排除了</span></span></font><span leaf=""><span textstyle="">HIF通路的干扰——Notch信号评分与HIF1通路无显著关联，且HIF1α/2α敲除不影响NICD1诱导的血管生成，证实</span></span><b><span leaf=""><span textstyle="">Notch信号通过HIF非依赖途径调控血管生成</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiapEPGItCUibC6t4WIyT4sUs38uU2Zd6pichNwkOJlLlNTzX5bwqHldI4A/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="1.276100086281277" data-s="300,640" data-type="jpeg" data-w="1159" type="block" data-imgfileid="503761779" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiapEPGItCUibC6t4WIyT4sUs38uU2Zd6pichNwkOJlLlNTzX5bwqHldI4A/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">机制解析：</span></span></font></b><b><span leaf=""><span textstyle="">NOTCH1-USP5-STAT3轴是血管生成的"分子开关"</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">明确</span></span></font><span leaf=""><span textstyle="">Notch信号的促血管生成作用后，研究团队通过多组学整合分析，锁定了关键调控轴——NOTCH1-USP5-STAT3。</span></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><b><span leaf=""><span textstyle="">USP5是Notch信号的直接下游靶基因</span></span></b><b><span><p></p></span></b></p><p><span leaf=""><span textstyle="">Notch信号的经典功能是通过NICD1进入细胞核，与RBPJ复合体结合激活靶基因转录。研究者通过NICD1的CUT&amp;Tag测序，</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">在</span></span></font><span leaf=""><span textstyle="">ESCC细胞中鉴定到2067个NICD1 结合位点，其中44.8%位于转录起始位点（TSS）附近</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">，</span><span textstyle="">包括已知靶基因</span></span></font><span leaf=""><span textstyle="">HES1、HES4（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">结合</span></span></font><span leaf=""><span textstyle="">NOTCH1敲除后的RNA测序数据，发现</span></span><b><span leaf=""><span textstyle="">31个基因同时存在NICD1启动子结合且mRNA水平下调</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">，</span><span textstyle="">其中</span></span></font><span leaf=""><span textstyle="">USP5（泛素特异性蛋白酶5）的CUT&amp;Tag信号强度仅次于HES1（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。组织芯片验证显示，</span></span></font><b><span leaf=""><span textstyle="">USP5与NICD1表达呈显著正相关</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">，</span><span textstyle="">且</span></span></font><span leaf=""><span textstyle="">NOTCH1 敲除可显著降低USP5的mRNA和蛋白水平，而NICD1过表达则上调 USP5（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">进一步的机制验证显示：</span></span></font></b><span leaf=""><span textstyle="">USP5启动子存在RBPJ结合基序（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）；</span></span></font><span leaf=""><span textstyle="">ChIP-qPCR证实 NICD1/RBPJ复合体可直接结USP5启动子（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）；报告基因实验显示，野生型</span></span></font><span leaf=""><span textstyle="">USP5启动子的uciferase活性显著高于突变型（缺失RBPJ结合位点），且NOTCH1敲除可抑制野生型启动子活性（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">4</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。这些结果明确证实，</span></span></font><b><span leaf=""><span textstyle="">USP5是Notch信号的直接转录靶基因</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><b><span leaf=""><span textstyle="">USP5通过稳定STAT3促进促血管生成因子分泌</span></span></b><b><span><p></p></span></b></p><p><span leaf=""><span textstyle="">USP5作为去泛素化酶（DUB），可通过去除靶蛋白的泛素链增强其稳定性。研究发现，</span></span><b><span leaf=""><span textstyle="">USP5在ESCC中的作用与STAT3密切相关</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">：</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">关联证据：</span></span></font></b><span leaf=""><span textstyle="">ESCC组织芯片中，USP5水平与CD31密度正相关，且高USP5患者生存期更短（HR=1.5）；蛋白质组学数据分析显示，USP5与STAT3蛋白水平呈显著正相关（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">5</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaziczU9WeAphwWudVYlghFU8QPUcwD5j6BRDB1KnaMZIKwRpEEuAy9Vg/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="1.2986899563318777" data-s="300,640" data-type="jpeg" data-w="1145" type="block" data-imgfileid="503761780" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaziczU9WeAphwWudVYlghFU8QPUcwD5j6BRDB1KnaMZIKwRpEEuAy9Vg/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">5</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">功能验证：</span></span></font></b><span leaf=""><span textstyle="">USP5敲除可显著降低ESCC细胞中STAT3（总蛋白和磷酸化形式）及下游促血管生成因子（VEGF、ANGPT2、CXCL1）的水平，而USP5过表达则上调这些分子；条件培养基实验显示，</span></span><b><span leaf=""><span textstyle="">USP5敲除抑制HUVEC血管生成，过表达则促进，且这一效应可被STAT3过表达逆转</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><span leaf=""><span textstyle="">5）。</span></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">分子机制：</span></span></font></b><span leaf=""><span textstyle="">CHX（蛋白合成抑制剂）实验证实，</span></span><b><span leaf=""><span textstyle="">USP5过表达可延长STAT3的半衰期</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">；</span><span textstyle="">共定位和免疫共沉淀实验显示</span></span></font><span leaf=""><span textstyle="">USP5与STAT3直接相互作用；泛素化实验表明，</span><span textstyle="">USP5 可特异性去除STAT3的K48连接泛素链（促降解型），从而抑制其蛋白酶体降解（图 5</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">）</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">这些结果揭示，</span></span></font><b><span leaf=""><span textstyle="">USP5是Notch信号下游的关键效应分子，通过去泛素化稳定STAT3，进而促进促血管生成因子分泌</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">完整调控轴：</span></span></font><span leaf=""><span textstyle="">NOTCH1→USP5→STAT3→血管生成</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">综合上述发现，研究提出了完整的调控模型（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">6</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）：在</span></span></font><span leaf=""><span textstyle="">ESCC中</span><span textstyle="">，</span></span><b><span leaf=""><span textstyle="">Notch信号异常激活后，NICD1进入细胞核与RBPJ结合，转录上调USP5；USP5通过去除STAT3的 K48泛素链增强其稳定性；稳定的STAT3进入细胞核，促进VEGF、ANGPT2、CXCL1 等促血管生成因子的表达和分泌，最终加速肿瘤血管生成</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span><span textstyle="">而在</span></span></font><span leaf=""><span textstyle="">NOTCH1突变（主要为EGF样结构域突变，导致配体结合障碍）的ESCC中，这一轴无法激活，血管生成能力减弱，这也</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">解释了为何</span></span></font><span leaf=""><span textstyle="">NOTCH1突变克隆</span></span></b><b><font face="微软雅黑"><span leaf=""><span textstyle="">在</span></span></font></b><b><span leaf=""><span textstyle="">ESCC中较正常上皮更少——因无法满足肿瘤快速生长的血管需求</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiagkPtdRw9nGQcfdc0Yr2CzibwQaH0vM0eNQnAiaicmMOnD80lCr7v47ErQ/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="0.8140625" data-s="300,640" data-type="jpeg" data-w="1280" type="block" data-imgfileid="503761781" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiagkPtdRw9nGQcfdc0Yr2CzibwQaH0vM0eNQnAiaicmMOnD80lCr7v47ErQ/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">6</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">临床转化：</span></span></font></b><b><span leaf=""><span textstyle="">USP5是ESCC抗血管生成治疗的"新靶点"</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">基于</span></span></font><span leaf=""><span textstyle="">NOTCH1-USP5-STAT3轴的关键作用，研究团队评估了靶向USP5的治疗潜力，为ESCC治疗提供了新策略。</span></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><b><span leaf=""><span textstyle="">USP5抑制剂单药的抗瘤活性</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">鉴于</span></span></font><span leaf=""><span textstyle="">Notch抑制剂（如γ</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">-</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">分泌酶抑制剂）存在脱靶效应和毒性，研究者选择</span></span></font><span leaf=""><span textstyle="">USP5作为更特异性的靶点。使用USP5抑制剂EOAI3402143（已在结直肠癌、黑色素瘤中显示活性）处理NICD1过表达的ESCC移植瘤模型，结果显示</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">：</span></span></font><b><span leaf=""><span textstyle="">EOAI3402143可显著抑制肿瘤生长，且对NICD1过表达肿瘤的抑制效果更强</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">；</span><span textstyle="">治疗后肿瘤微血管密度显著降低，</span></span></font><span leaf=""><span textstyle="">STAT3表达下调（图</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">7</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">）。</span></span></font><span><p></p></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaIO87qycZTKkTWyhLicad8wjGcRXZUpIiaRRIiaXaNKTL9SYamdLGZqRAw/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="1.2269387755102041" data-s="300,640" data-type="jpeg" data-w="1225" type="block" data-imgfileid="503761782" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaIO87qycZTKkTWyhLicad8wjGcRXZUpIiaRRIiaXaNKTL9SYamdLGZqRAw/640?wx_fmt=jpeg&amp;from=appmsg"></section><p><font face="微软雅黑"><span leaf=""><span textstyle="">图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">7</span></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">进一步实验排除了</span></span></font><span leaf=""><span textstyle="">EOAI3402143对其他去泛素化酶（USP9X、USP24）的干扰，证实其通过抑制USP5-STAT3轴发挥作用。</span></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><b><span leaf=""><span textstyle="">USP5抑制剂与化疗的协同效应</span></span></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">临床中抗血管生成治疗常与化疗联合以增强疗效。研究发现，</span></span></font><b><span leaf=""><span textstyle="">EOAI3402143与5-FU/顺铂（ESCC常用化疗方案）联合使用时，对ESCC移植瘤的生长抑制和血管生成阻断效果显著优于单药</span></span></b><font face="微软雅黑"><span leaf=""><span textstyle="">（图</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">7</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">），</span></span></font><b><font face="微软雅黑"><span leaf=""><span textstyle="">且不增加小鼠体重下降等毒性</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">。</span><span textstyle="">这一结果为临床制定</span></span></font><span leaf=""><span textstyle="">"USP5抑制剂</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">+</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">化疗</span></span></font><span leaf=""><span textstyle="">"的联合方案提供了直接依据。</span></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">总结与展望</span></span></font></b><b><span><p></p></span></b></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">本研究系统阐明了</span></span></font><span leaf=""><span textstyle="">Notch信号在ESCC中的促血管生成机制：</span></span><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">临床关联：</span></span></font></b><span leaf=""><span textstyle="">Notch激活与</span></span><b><font face="微软雅黑"><span leaf=""><span textstyle="">血管密度、晚期分期和不良预后正相关</span></span></font></b><b><font face="微软雅黑"><span leaf=""><span textstyle="">；</span></span></font></b><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">机制创新：</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">首次发现</span></span></font><span leaf=""><span textstyle="">USP5是Notch下游效应分子，通过去泛素化稳定STAT3驱动血管生成</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">；</span></span></font><span><p></p></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">治疗价值：</span></span></font></b><span leaf=""><span textstyle="">USP5抑制剂联合化疗展现显著协同抗肿瘤效应</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font></p><p><span leaf=""><br></span></p><p><b><font face="微软雅黑"><span leaf=""><span textstyle="">未来研究方向包括：</span></span></font></b><font face="微软雅黑"><span leaf=""><span textstyle="">探索</span></span></font><span leaf=""><span textstyle="">USP5在ESCC转移和免疫逃逸中的作用</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">，优化靶向</span></span></font><span leaf=""><span textstyle="">USP5的递送系统以提高疗效</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">，开展基于</span></span></font><span leaf=""><span textstyle="">NOTCH1-USP5-STAT3轴活化程度的患者分层治疗</span></span><font face="微软雅黑"><span leaf=""><span textstyle="">。</span></span></font></p><p><font face="微软雅黑"><span leaf=""><br></span></font><span><p></p></span></p><p><font face="微软雅黑"><span leaf=""><span textstyle="">本研究通过临床</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">-</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">基础</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">-</span></span></font><font face="微软雅黑"><span leaf=""><span textstyle="">转化的全链条证据，首次揭示</span></span></font><span leaf=""><span textstyle="">Notch信号通过NOTCH1-USP5-STAT3轴驱动ESCC血管生成的新机制，不仅深化了对ESCC进展分子机制的理解，更为开发靶向USP5的治疗策略提供了坚实依据。这一发现为ESCC的精准治疗开辟了新路径，具有重要的科学价值和临床意义。</span></span></p><p><span leaf=""><br></span></p><section data-pm-slice="13 4 []"><section><section><section><section><section><section><section><section><span><strong><span><span leaf="">向中国医师致敬！</span></span></strong></span></section></section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/640?wx_fmt=png&amp;from=appmsg" data-ratio="1" data-s="300,640" data-type="png" data-w="150" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/0?wx_fmt=png&amp;from=appmsg" data-cropselx2="185" data-cropsely2="185" data-imgfileid="503761775" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWicCbIFYkKGicQ0M01NY6zNiaCF3Q9zXFWOROfrWyLX3jUtqaia1Uumwdb8rBS2YPz2ICZcKMIdSoBKw/640?wx_fmt=png&amp;from=appmsg"></section></section><section><section><section><section><p><span><strong><span leaf="">多组学，多维度探究癌症免疫机制</span></strong></span></p></section></section></section></section></section></section></section></section></section></section></section><section data-pm-slice="5 9 []"><section><section><strong><span leaf="">最新文章汇总</span></strong><span><span leaf="">（持续更新ing）</span></span></section></section><section data-width="100%"><span leaf=""><br></span></section></section><section><section><section><section><span leaf=""><br></span></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span><span leaf="">最新热点方向</span></span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span><span leaf="">1、<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651241298&amp;idx=1&amp;sn=647da856830ce46117b37d14978234d2&amp;scene=21#wechat_redirect" textvalue="Cell重磅！衰老的标志从12个增加到14个！" data-itemshowtype="0" linktype="text" data-linktype="2">Cell重磅！衰老的标志从12个增加到14个！</a></span></span><span><span leaf=""><br></span></span></p><p><span><span leaf="">2、<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651241135&amp;idx=1&amp;sn=b6cb9f56c2d0f0c153e730b21eb38a40&amp;scene=21#wechat_redirect" textvalue="汪汪队立大功！剑桥大学带着拉布拉多登上Science封面，贪吃竟成科研密码" data-itemshowtype="0" linktype="text" data-linktype="2">汪汪队立大功！剑桥大学带着拉布拉多登上Science封面，贪吃竟成科研密码</a></span></span><span leaf=""><br></span></p><p><span><span leaf="">3、<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651240871&amp;idx=1&amp;sn=c40b620d4a2819f832bb61264ddd8974&amp;scene=21#wechat_redirect" textvalue="癌细胞的顶级“阳谋”！Cancer cell揭秘癌细胞如何利用精氨酸策反巨噬细胞，建起免疫逃逸堡垒" data-itemshowtype="0" linktype="text" data-linktype="2">癌细胞的顶级“阳谋”！Cancer cell揭秘癌细胞如何利用精氨酸策反巨噬细胞，建起免疫逃逸堡垒</a></span></span></p><p><span><span leaf="">4、<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651240818&amp;idx=1&amp;sn=173b98354e5b5742d03d0251333181d5&amp;scene=21#wechat_redirect" textvalue="打破常识！Science重磅揭示中年发福真相：脂肪细胞不是躺平了，而是“卷疯了”！" data-itemshowtype="0" linktype="text" data-linktype="2">打破常识！Science重磅揭示中年发福真相：脂肪细胞不是躺平了，而是“卷疯了”！</a></span></span></p><p><span><span leaf="">5、<a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651240777&amp;idx=1&amp;sn=9ef6dcd741b185b458186baac4e88ad5&amp;scene=21#wechat_redirect" textvalue="不是我吹，2025年研究热点往这方向走就对了！！" data-itemshowtype="0" linktype="text" data-linktype="2">不是我吹，2025年研究热点往这方向走就对了！！</a></span><span leaf=""><br></span></span></p></section></section></section><section><section><section><section><span leaf=""><br></span></section></section><section data-width="100%"><section><span><strong data-brushtype="text"><strong><span><span leaf="">生信人课堂</span></span></strong></strong></span></section></section></section><section><section data-autoskip="1"><p><span><span leaf="">1、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651231246&amp;idx=2&amp;sn=e9a3817e55f8b9a216317cf792b2cdeb&amp;chksm=8b5f9361bc281a77de8c15a66cf6f38a5b4b5a529d09bfbe6f990cac37fc7558b71117332237&amp;scene=21#wechat_redirect" textvalue="多组学水平的孟德尔随机化分析套路" data-itemshowtype="0" linktype="text" data-linktype="2">多组学水平的孟德尔随机化分析套路</a></span></span></p><p><span><span leaf="">2、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651231263&amp;idx=2&amp;sn=f5b705a49c16d2c5e16f3596c83aa4e6&amp;chksm=8b5f9370bc281a663e6fa184c5f711684ea900043b54fb93289d0383017393a7fd0eed7acad9&amp;scene=21#wechat_redirect" textvalue="单细胞+空转王炸组合，探索骨骼肌纤维化巨噬细胞" data-itemshowtype="0" linktype="text" data-linktype="2">单细胞+空转王炸组合，探索骨骼肌纤维化巨噬细胞</a></span></span></p><p><span><span leaf="">3、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651231475&amp;idx=2&amp;sn=1cc3634bbbaf2b01dffe537173c330bd&amp;chksm=8b5f939cbc281a8a38b5d224f8b572fb9a1fc9bea648164d9840a40c8bd4dd8e7292ad0eeb28&amp;scene=21#wechat_redirect" textvalue="以小博大，紧张刺激：肿瘤耐药研究，从基因到网络" data-itemshowtype="0" linktype="text" data-linktype="2">以小博大，紧张刺激：肿瘤耐药研究，从基因到网络</a></span></span></p><p><span><span leaf="">4、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651231403&amp;idx=2&amp;sn=a24c3de06e79cee6f60fce4de00992cc&amp;chksm=8b5f93c4bc281ad2dd8c796dcd7972b5cb0bc35cd168b52ddb18146c04657e65592a5544cb20&amp;scene=21#wechat_redirect" textvalue="零基础入门-单细胞课程" data-itemshowtype="0" linktype="text" data-linktype="2">零基础入门-单细胞课程</a></span></span></p><p><span><span leaf="">5、<a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651231220&amp;idx=2&amp;sn=1018e94760161600e02a274a0f6b5f50&amp;chksm=8b5f949bbc281d8d5ab43f21cce6de6ed329614b413197da8e6d20abdb9d32b25287ad4c9857&amp;scene=21#wechat_redirect" textvalue="史上最全格局打开，细讲基因组学，确定不来学学？" data-itemshowtype="0" linktype="text" data-linktype="2">史上最全格局打开，细讲基因组学，确定不来学学？</a></span></span></p><p><span leaf=""><br></span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651228766&amp;idx=5&amp;sn=0b8b7808bcf30dc95a7fab203c9db627&amp;scene=21#wechat_redirect" textvalue="课题设计" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">  课题设计 </span></a></span><span leaf=""><span textstyle="">｜</span></span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651219968&amp;idx=3&amp;sn=86d6e913fa0e5b057c75096aad2cecee&amp;scene=21#wechat_redirect" textvalue="生信分析" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">生信分析</span></a></span><span leaf=""><span textstyle="">｜</span></span><span leaf=""><a target="_blank" href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651215445&amp;idx=3&amp;sn=c640ea6cda6054c21885f6389ea4cce1&amp;scene=21#wechat_redirect" textvalue="数字产品" data-itemshowtype="0" linktype="text" data-linktype="2"><span textstyle="">数字产</span></a><span textstyle="">品</span></span></p><p><span><span leaf="">概普生物 让科研丰富</span></span></p><section data-tools="135编辑器" data-id="125822" data-color="#00259f"><section data-bgw="266" data-ratio="0.8421052631578947" data-lazy-bgimg="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWQf4lNGt7ndITTGlJfQQRj5J9MY0iaU72BlQhcic3VQ7icPXoLq9Lo1IwibibRibWDNFzSWun5bdia5KrDw/640?wx_fmt=png" data-fail="0"><section data-width="40%"><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWQf4lNGt7ndITTGlJfQQRjQNcyveWAgggfVmFSjJBBtwccOfgX5MjcqYaMcUmQVKhpPicrdvyPBCg/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;randomid=oz1fi0e8&amp;tp=webp" alt="图片" data-ratio="1" data-type="jpeg" data-w="258" data-width="100%" data-imgfileid="503754393" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWQf4lNGt7ndITTGlJfQQRjQNcyveWAgggfVmFSjJBBtwccOfgX5MjcqYaMcUmQVKhpPicrdvyPBCg/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;randomid=oz1fi0e8&amp;tp=webp"></section></section><section data-width="60%"><section><section><section><strong data-brushtype="code"><span leaf="">生信人</span></strong></section><section><section><span leaf=""><br></span></section></section></section></section><section><span leaf="">专注于基因技术相关知识分享</span></section><section><span leaf="">扫码关注 获取更多</span></section></section></section></section><p><span leaf=""><br></span></p><section data-tools="135编辑器" data-id="118316" data-color="#00259f"><section><section><section><p><span leaf=""><br></span></p><section><span leaf=""><br></span></section><p><span leaf=""><br></span></p></section><section><strong data-brushtype="text"><span leaf="">END</span></strong></section></section></section></section></section></section></section><p><span leaf=""><br></span></p><p><span leaf=""><br></span><span><p></p></span></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/uCltgP-sjxXjCjoaT7C3iw",target="_blank" rel="noopener noreferrer">原文链接</a>
